On March 17, Medytox, a biopharmaceutical company, announced that a comparative research paper proving the heat stability of its non-animal liquid botulinum toxin product, 'Innotox', has been published in the international journal for cosmetic surgery, Aesthetic Surgery Journal Open Forum.


Medytox's non-animal liquid botulinum toxin product, 'Innotox'. Medytox

Medytox's non-animal liquid botulinum toxin product, 'Innotox'. Medytox

View original image

The study exposed 'Innotox' and powder-type botulinum toxin products using human serum albumin (HSA) as a stabilizer—the comparator group—to a high temperature of 60°C for 25 minutes, simulating combined treatment conditions with energy-based devices (EBD) such as high-intensity focused ultrasound and radiofrequency. According to potency analysis based on the mouse median lethal dose (LD50) assay, 'Innotox' maintained its potency almost entirely after heat exposure, whereas the comparator group showed up to a 51% decrease in efficacy per product under the same conditions.


The research team suggested that the inclusion of polysorbate 20 and L-methionine in 'Innotox' is likely the reason for its resistance to protein denaturation and high temperatures. They also explained that botulinum toxin products like 'Innotox', which have been proven to maintain heat stability during combined procedures with energy-based devices (EBD), may be considered as a treatment option.


A Medytox representative stated, "This study has scientifically proven that 'Innotox' can be considered the optimal option for combined procedures with energy-based devices (EBD). Going forward, we will further strengthen our market position based on product differentiation compared to competitors."



Currently, most commercially available botulinum toxin products are in powder form and require dilution with saline before use. In contrast, 'Innotox', developed by Medytox in 2013 as the world's first non-animal liquid botulinum toxin product, eliminates the dilution step, thereby blocking potential contamination during dilution and improving user convenience. Additionally, unlike conventional products that use human serum albumin (HSA) as a stabilizer, 'Innotox' excludes animal-derived ingredients in the manufacturing process and utilizes non-animal stabilizers such as polysorbate 20 and L-methionine, reducing the potential risk of infection from animal-derived components.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing